Susquehanna International Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,300
| Closed | -$305K | – | 14859 |
|
|
2022
Q2 | $305K | Buy |
+9,300
| New | +$294K | ﹤0.01% | 9535 |
|
|
2021
Q3 | – | Sell |
-9,000
| Closed | -$234K | – | 13939 |
|
|
2021
Q2 | $234K | Sell |
9,000
-15,300
| -63% | -$416K | ﹤0.01% | 11269 |
|
|
2021
Q1 | $622K | Buy |
24,300
+5,800
| +31% | +$149K | ﹤0.01% | 8967 |
|
|
2020
Q4 | $371K | Sell |
18,500
-2,400
| -11% | -$47K | ﹤0.01% | 8871 |
|
|
2020
Q3 | $358K | Sell |
20,900
-16,300
| -44% | -$308K | ﹤0.01% | 8355 |
|
|
2020
Q2 | $812K | Sell |
37,200
-5,700
| -13% | -$130K | ﹤0.01% | 6362 |
|
|
2020
Q1 | $992K | Buy |
42,900
+30,600
| +249% | +$889K | ﹤0.01% | 5427 |
|
|
2019
Q4 | $406K | Buy |
12,300
+2,000
| +19% | +$64.1K | ﹤0.01% | 7397 |
|
|
2019
Q3 | $328K | Buy |
+10,300
| New | +$300K | ﹤0.01% | 8107 |
|
|
2019
Q2 | – | Sell |
-21,500
| Closed | -$546K | – | 11071 |
|
|
2019
Q1 | $546K | Sell |
21,500
-148,800
| -87% | -$4.44M | ﹤0.01% | 6099 |
|
|
2018
Q4 | $5.79M | Buy |
170,300
+106,500
| +167% | +$3.46M | ﹤0.01% | 2133 |
|
|
2018
Q3 | $2.27M | Buy |
63,800
+14,100
| +28% | +$498K | ﹤0.01% | 3783 |
|
|
2018
Q2 | $1.72M | Buy |
49,700
+27,400
| +123% | +$960K | ﹤0.01% | 4277 |
|
|
2018
Q1 | $750K | Buy |
22,300
+12,700
| +132% | +$402K | ﹤0.01% | 5814 |
|
|
2017
Q4 | $367K | Sell |
9,600
-54,300
| -85% | -$2.17M | ﹤0.01% | 7218 |
|
|
2017
Q3 | $2.4M | Sell |
63,900
-4,600
| -7% | -$162K | ﹤0.01% | 3587 |
|
|
2017
Q2 | $2.56M | Buy |
68,500
+41,300
| +152% | +$1.49M | ﹤0.01% | 3447 |
|
|
2017
Q1 | $1.07M | Buy |
27,200
+700
| +3% | +$26.3K | ﹤0.01% | 4997 |
|
|
2016
Q4 | $922K | Sell |
26,500
-29,000
| -52% | -$1.14M | ﹤0.01% | 5706 |
|
|
2016
Q3 | $2.18M | Buy |
55,500
+27,900
| +101% | +$1.11M | ﹤0.01% | 3429 |
|
|
2016
Q2 | $1.04M | Buy |
27,600
+4,700
| +21% | +$157K | ﹤0.01% | 4805 |
|
|
2016
Q1 | $880K | Buy |
22,900
+11,800
| +106% | +$439K | ﹤0.01% | 5350 |
|
|
2015
Q4 | $533K | Buy |
11,100
+5,900
| +113% | +$273K | ﹤0.01% | 6637 |
|
|
2015
Q3 | $205K | Sell |
5,200
-200
| -4% | -$8.5K | ﹤0.01% | 8666 |
|
|
2015
Q2 | $230K | Sell |
5,400
-14,000
| -72% | -$558K | ﹤0.01% | 9055 |
|
|
2015
Q1 | $766K | Buy |
19,400
+13,800
| +246% | +$509K | ﹤0.01% | 6287 |
|
|
2014
Q4 | $202K | Sell |
5,600
-46,500
| -89% | -$1.56M | ﹤0.01% | 8803 |
|
|
2014
Q3 | $1.54M | Sell |
52,100
-57,000
| -52% | -$1.57M | ﹤0.01% | 5100 |
|
|
2014
Q2 | $2.74M | Sell |
109,100
-95,800
| -47% | -$2.37M | ﹤0.01% | 4056 |
|
|
2014
Q1 | $5.29M | Buy |
204,900
+109,600
| +115% | +$2.76M | ﹤0.01% | 2813 |
|
|
2013
Q4 | $2.14M | Buy |
95,300
+78,500
| +467% | +$1.52M | ﹤0.01% | 4151 |
|
|
2013
Q3 | $238K | Sell |
16,800
-4,100
| -20% | -$54.8K | ﹤0.01% | 7533 |
|
|
2013
Q2 | $285K | Buy |
+20,900
| New | +$285K | ﹤0.01% | 6882 |
|
Other funds holding NTUS
Susquehanna International Group's NTUS Position: Q1 2022 in Review
Susquehanna International Group sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 9,576 shares — an estimated $227K sold.
Susquehanna International Group first reported a position in NTUS in Q4 2013 and held it in 24 quarters. The position peaked at $5.19M in Q1 2014. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- Susquehanna International Group reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
- Susquehanna International Group sold 9,576 Natus Medical Inc shares in Q1 2022, an estimated $227K.
- Susquehanna International Group first reported a position in Natus Medical Inc in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's Natus Medical Inc position peaked at $5.19M in Q1 2014.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.